English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [335]
News [1546]
Articles [67]
Editorials [3]
Conferences [72]
elearning [15]
Combination immunotherapy shrank a variety of metastatic gastrointestinal cancers
Combination immunotherapy shrank a variety of metastatic gastrointestinal cancers
How inherited cancer risks can be used for effective personalised therapy
How inherited cancer risks can be used for effective personalised therapy
FDA approves cabozantinib for adults and peadiatric patients 12 years of age and older with pNET and epNET
FDA approves cabozantinib for adults and peadiatric patients 12 years of age and older with pNET and epNET
Hope for a complete cure for hepatocellular carcinoma: Combining lenvatinib and pembrolizumab with transarterial chemoembolization improves efficacy in treating hepatocellular carcinoma
Hope for a complete cure for hepatocellular carcinoma: Combining lenvatinib and pembrolizumab with transarterial...
Fatty liver linked to increased risk of death from several diseases
Fatty liver linked to increased risk of death from several diseases
Study introduces online tool to guide surgical decisions for gallbladder cancer
Study introduces online tool to guide surgical decisions for gallbladder cancer
Clinic researchers identify a measurable genetic mutation as a significant predictor of metastasis and survival in pancreatic cancer
Clinic researchers identify a measurable genetic mutation as a significant predictor of metastasis and survival in...
Removing a protein ‘signal jammer’ improves immunotherapy
Removing a protein ‘signal jammer’ improves immunotherapy
Isoleucyl-tRNA synthetase 2 (IARS2) promotes pancreatic ductal adenocarcinoma (PDAC)
Isoleucyl-tRNA synthetase 2 (IARS2) promotes pancreatic ductal adenocarcinoma (PDAC)
Immune subtyping and NK cell targeting: A new frontier for immune checkpoint inhibitor treatment in hepatocellular carcinoma
Immune subtyping and NK cell targeting: A new frontier for immune checkpoint inhibitor treatment in hepatocellular...
<123456...155>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top